DNA Vaccine using Electro-Portable Microneedle Patch
- Funded by RIGHT Foundation
- Total publications:3 publications
Grant number: 7867
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$423,000Funder
RIGHT FoundationPrincipal Investigator
N/A
Research Location
41Lead Research Institution
AbionResearch Priority Alignment
N/A
Research Category
N/A
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Abion is collaborating with Raphas to develop a DNA vaccine for COVID-19 using a microarray patch combined with a portable electroporation device (eMAP) and powered by an integrated battery. This unique combination of various technologies of DNA vaccine, microarray patch and electroporation could lead to significant advancement in delivery methods for DNA vaccines. If validated, the platform technology has the potential to enable the rapid production of DNA vaccines for future COVID-19 variants and other diseases.
3 Publications linked via Europe PMC
Last Updated:6 days ago
View all publications at Europe PMC